| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $261.2M | — | -0.3% |
| Cost of Revenue | $99.5M | — | -5.1% |
| Gross Profit | $161.7M | — | +2.9% |
| R&D Expense | $4.6M | — | -77.3% |
| SG&A Expense | $77.6M | — | -4.3% |
| Operating Income | $83.3M | — | +190.2% |
| Pre-tax Income | $58.9M | — | +8514.3% |
| Income Tax | $14.8M | — | +2214.3% |
| Net Income | $44.1M | — | — |
| EPS (Basic) | $0.75 | — | — |
| EPS (Diluted) | $0.74 | — | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $201.3M | -10.7% | -4.1% |
| Accounts Receivable | $159.2M | +9.3% | -12.0% |
| Inventory | $181.8M | +1.8% | +7.5% |
| Current Assets | $620.2M | -1.8% | -7.0% |
| Total Assets | $1.06B | -2.5% | -7.5% |
| Current Liabilities | $234.7M | -10.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.2M | — | +424.5% |
| Capital Expenditures | $600K | — | -60.0% |
| Investing Cash Flow | $9.5M | — | +733.3% |
| Financing Cash Flow | -$51.6M | — | -14.2% |
| Free Cash Flow | $16.6M | — | +344.1% |
| -21.3% |
| Long-term Debt | $1.35B | -3.2% | -11.8% |
| Stockholders' Equity | -$613.1M | +5.8% | +20.3% |